Anna Willems‐Widyastuti

1.4k total citations
26 papers, 1.1k citations indexed

About

Anna Willems‐Widyastuti is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Anna Willems‐Widyastuti has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Epidemiology. Recurrent topics in Anna Willems‐Widyastuti's work include Transplantation: Methods and Outcomes (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Neonatal Respiratory Health Research (6 papers). Anna Willems‐Widyastuti is often cited by papers focused on Transplantation: Methods and Outcomes (14 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Neonatal Respiratory Health Research (6 papers). Anna Willems‐Widyastuti collaborates with scholars based in Belgium, Netherlands and Switzerland. Anna Willems‐Widyastuti's co-authors include Lieven Dupont, Bart Vanaudenaerde, Dirk Van Raemdonck, Stéphanie I. De Vleeschauwer, Stijn E. Verleden, Geert M. Verleden, Robin Vos, Hari S. Sharma, Andor R. Kranenburg and Vijay K. T. Alagappan and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and European Respiratory Journal.

In The Last Decade

Anna Willems‐Widyastuti

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Willems‐Widyastuti Belgium 17 589 581 192 179 170 26 1.1k
Rebecca A. Shilling United States 17 164 0.3× 268 0.5× 79 0.4× 138 0.8× 98 0.6× 33 799
J. Parmar United Kingdom 16 257 0.4× 291 0.5× 65 0.3× 66 0.4× 94 0.6× 41 855
Jochum Prop Netherlands 17 254 0.4× 614 1.1× 109 0.6× 53 0.3× 205 1.2× 38 866
Matthieu Thumerel France 15 406 0.7× 126 0.2× 56 0.3× 228 1.3× 28 0.2× 44 766
S. K. Savik United States 7 224 0.4× 363 0.6× 101 0.5× 40 0.2× 117 0.7× 9 544
Thomas Savage United States 13 77 0.1× 157 0.3× 69 0.4× 29 0.2× 104 0.6× 24 789
Jean-Guy Lachance Canada 11 80 0.1× 568 1.0× 94 0.5× 48 0.3× 345 2.0× 24 1.1k
Robert Lischke Czechia 15 377 0.6× 346 0.6× 69 0.4× 27 0.2× 64 0.4× 107 979
Natalie De Ruyck Belgium 19 341 0.6× 533 0.9× 58 0.3× 1.5k 8.5× 24 0.1× 38 2.4k
Stéphanie Coupel France 13 101 0.2× 207 0.4× 194 1.0× 33 0.2× 298 1.8× 19 852

Countries citing papers authored by Anna Willems‐Widyastuti

Since Specialization
Citations

This map shows the geographic impact of Anna Willems‐Widyastuti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Willems‐Widyastuti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Willems‐Widyastuti more than expected).

Fields of papers citing papers by Anna Willems‐Widyastuti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Willems‐Widyastuti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Willems‐Widyastuti. The network helps show where Anna Willems‐Widyastuti may publish in the future.

Co-authorship network of co-authors of Anna Willems‐Widyastuti

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Willems‐Widyastuti. A scholar is included among the top collaborators of Anna Willems‐Widyastuti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Willems‐Widyastuti. Anna Willems‐Widyastuti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Austin, Claire C., et al.. (2020). COVID-19 Surveillance Data and Models: Review and Analysis, Part 1. SSRN Electronic Journal.
2.
Sharma, Hari S., Vijay K. T. Alagappan, Anna Willems‐Widyastuti, Wolter J. Mooi, & W. de Boer. (2013). Nitric Oxide Donors Augment Interleukin-1β-Induced Vascular Endothelial Growth Factor in Airway Smooth Muscle Cells. Cell Biochemistry and Biophysics. 67(2). 247–254. 2 indexed citations
3.
Vleeschauwer, Stéphanie De, Wolfgang Jungraithmayr, Shana Wauters, et al.. (2012). Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks. PLoS ONE. 7(1). e29802–e29802. 33 indexed citations
4.
Willems‐Widyastuti, Anna, Bart Vanaudenaerde, Robin Vos, et al.. (2011). MAP kinases mediate FGF-induced expression and release of VEGF in human airway smooth muscle cells: The role of azithromycin. European Respiratory Journal. 38(Suppl 55). p753–p753. 1 indexed citations
5.
Vleeschauwer, Stéphanie I. De, Shana Wauters, Lieven Dupont, et al.. (2011). Medium-term outcome after lung transplantation is comparable between brain-dead and cardiac-dead donors. The Journal of Heart and Lung Transplantation. 30(9). 975–981. 59 indexed citations
6.
Verleden, Stijn E., Robin Vos, Veerle Mertens, et al.. (2011). Heterogeneity of chronic lung allograft dysfunction: Insights from protein expression in broncho alveolar lavage. The Journal of Heart and Lung Transplantation. 30(6). 667–673. 32 indexed citations
7.
Willems‐Widyastuti, Anna, Bart Vanaudenaerde, Robin Vos, et al.. (2011). Azithromycin Attenuates Fibroblast Growth Factors Induced Vascular Endothelial Growth Factor Via p38MAPK Signaling in Human Airway Smooth Muscle Cells. Cell Biochemistry and Biophysics. 67(2). 331–339. 32 indexed citations
8.
Verleden, Geert M., Robin Vos, Stijn E. Verleden, et al.. (2011). Survival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction. Transplantation. 92(6). 703–708. 81 indexed citations
9.
Vanaudenaerde, Bart, Stijn E. Verleden, Robin Vos, et al.. (2010). Innate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders. American Journal of Respiratory and Critical Care Medicine. 183(8). 977–986. 79 indexed citations
10.
Vos, Robin, Bart Vanaudenaerde, Stijn E. Verleden, et al.. (2010). A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. European Respiratory Journal. 37(1). 164–172. 177 indexed citations
11.
Vos, Robin, Bart Vanaudenaerde, Stijn E. Verleden, et al.. (2010). Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. The Journal of Heart and Lung Transplantation. 29(11). 1259–1269. 31 indexed citations
12.
Decraene, Ann, Anna Willems‐Widyastuti, Ahmad Kasran, et al.. (2010). Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients. Respiratory Research. 11(1). 177–177. 75 indexed citations
13.
Vos, Robin, Bart Vanaudenaerde, Stijn E. Verleden, et al.. (2010). Diagnostic Value of Antibodies Against Pseudomonas aeruginosa in Bronchoalveolar Lavage Fluid After Lung Transplantation. Transplantation Proceedings. 42(10). 4415–4420. 3 indexed citations
14.
Vos, Robin, Bart Vanaudenaerde, Stijn E. Verleden, et al.. (2010). Long-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer?. The Journal of Heart and Lung Transplantation. 29(12). 1358–1368. 69 indexed citations
15.
Vos, Robin, Bart Vanaudenaerde, Stéphanie I. De Vleeschauwer, et al.. (2009). C-Reactive Protein in Bronchoalveolar Lavage Fluid is Associated With Markers of Airway Inflammation After Lung Transplantation. Transplantation Proceedings. 41(8). 3409–3413. 13 indexed citations
16.
Verleden, Geert M., Robin Vos, Stéphanie I. De Vleeschauwer, et al.. (2009). Obliterative bronchiolitis following lung transplantation: from old to new concepts?. Transplant International. 22(8). 771–779. 46 indexed citations
17.
Vanaudenaerde, Bart, Robin Vos, Isabelle Meyts, et al.. (2008). Macrolide Therapy Targets a Specific Phenotype in Respiratory Medicine: From Clinical Experience to Basic Science and Back. Inflammation & Allergy - Drug Targets. 7(4). 279–287. 19 indexed citations
18.
Parameswaran, Krishnan, Anna Willems‐Widyastuti, Vijay K. T. Alagappan, et al.. (2006). Role of Extracellular Matrix and Its Regulators in Human Airway Smooth Muscle Biology. Cell Biochemistry and Biophysics. 44(1). 139–146. 81 indexed citations
19.
Kranenburg, Andor R., Anna Willems‐Widyastuti, Peter Sterk, et al.. (2006). Enhanced Bronchial Expression of Extracellular Matrix Proteins in Chronic Obstructive Pulmonary Disease. American Journal of Clinical Pathology. 126(5). 725–735. 112 indexed citations
20.
Kranenburg, Andor R., Anna Willems‐Widyastuti, Wolter J. Mooi, et al.. (2005). Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF‐1, FGF‐2, and FGFR‐1. The Journal of Pathology. 206(1). 28–38. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026